US Stock MarketDetailed Quotes

CVS CVS Health

Watchlist
  • 55.150
  • -1.160-2.06%
Close May 2 16:00 ET
  • 55.250
  • +0.100+0.18%
Post 19:59 ET
69.23BMarket Cap9.68P/E (TTM)

CVS Health Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.08%4.9B
-17.01%13.43B
-35.04%-2.64B
-70.23%2.72B
8.54%5.91B
108.76%7.44B
-11.43%16.18B
-148.74%-1.95B
65.24%9.12B
-6.91%5.44B
Net income from continuing operations
-47.53%1.12B
93.39%8.37B
-12.22%2.05B
166.64%2.27B
-37.02%1.91B
-9.04%2.14B
-45.84%4.33B
68.13%2.33B
-314.18%-3.4B
8.89%3.04B
Operating gains losses
----
-83.04%349M
--0
----
----
----
355.31%2.06B
-367.42%-238M
--2.52B
----
Depreciation and amortization
13.69%1.14B
3.36%4.37B
8.72%1.13B
7.33%1.13B
2.03%1.1B
-4.58%1B
-5.84%4.22B
-4.22%1.04B
-7.41%1.05B
-4.84%1.08B
Deferred tax
-240.00%-217M
66.68%-676M
-271.74%-316M
77.28%-447M
4.23%-68M
188.57%155M
-404.73%-2.03B
-24.28%184M
-615.27%-1.97B
65.20%-71M
Other non cash items
----
25.30%416M
----
----
----
----
185.13%332M
----
----
----
Change In working capital
-32.60%2.72B
-99.78%15M
-5.83%-6.04B
-106.77%-732M
87.22%2.75B
1,547.76%4.04B
76.77%6.82B
-6,375.82%-5.71B
398.98%10.81B
-25.63%1.47B
-Change in receivables
500.53%3.01B
-110.70%-6.26B
-143.24%-2.34B
-559.59%-3.12B
92.64%-53M
61.82%-751M
-9.91%-2.97B
-220.10%-962M
160.54%678M
-147.42%-720M
-Change in inventory
100.48%1.66B
185.92%1.23B
92.94%-72M
44.00%-495M
11.85%972M
307.00%828M
-295.24%-1.44B
-181.77%-1.02B
-110.48%-884M
36.21%869M
-Change in payables and accrued expense
-73.48%843M
-23.61%4.01B
-21.72%-3.13B
-35.01%2.93B
1,320.00%1.04B
-6.61%3.18B
75.13%5.25B
-94.70%-2.57B
79.20%4.51B
-109.08%-85M
-Change in other current assets
-125.98%-2.84B
-3.87%-510M
103.24%8M
840.48%395M
451.61%342M
-260.63%-1.26B
-1,536.67%-491M
-525.86%-247M
-67.94%42M
-7.46%62M
-Change in other current liabilities
-97.74%46M
-76.17%1.54B
44.16%-507M
-106.88%-445M
-66.10%456M
558.56%2.04B
126.30%6.46B
-199.13%-908M
509.80%6.47B
114.17%1.35B
Cash from discontinued investing activities
Operating cash flow
-34.08%4.9B
-17.01%13.43B
-35.04%-2.64B
-70.23%2.72B
8.54%5.91B
108.76%7.44B
-11.43%16.18B
-148.74%-1.95B
65.24%9.12B
-6.91%5.44B
Investing cash flow
Cash flow from continuing investing activities
75.41%-2.09B
-313.89%-20.89B
-943.70%-1.24B
4.22%-771M
-386.48%-10.36B
-327.20%-8.51B
4.07%-5.05B
91.74%-119M
4.96%-805M
-92.41%-2.13B
Net PPE purchase and sale
28.35%-705M
-11.15%-3.03B
-32.41%-911M
6.03%-545M
-44.85%-591M
6.37%-984M
-8.21%-2.73B
-15.24%-688M
4.61%-580M
16.05%-408M
Net business purchase and sale
99.65%-25M
-1,096.83%-16.61B
-117.88%-120M
-300.00%-18M
-355.12%-9.38B
-101,242.86%-7.09B
-850.68%-1.39B
6,200.00%671M
133.33%9M
-8,487.50%-2.06B
Net investment purchase and sale
-198.07%-1.39B
-29.20%-1.31B
-108.85%-236M
13.78%-219M
-254.33%-392M
48.34%-467M
62.57%-1.02B
86.85%-113M
-8.09%-254M
137.97%254M
Net other investing changes
-9.68%28M
-20.00%68M
127.27%25M
-45.00%11M
-98.82%1M
200.00%31M
-30.33%85M
-59.26%11M
-13.04%20M
--85M
Cash from discontinued investing activities
Investing cash flow
75.41%-2.09B
-313.89%-20.89B
-943.70%-1.24B
4.22%-771M
-386.48%-10.36B
-327.20%-8.51B
4.07%-5.05B
91.74%-119M
4.96%-805M
-92.41%-2.13B
Financing cash flow
Cash flow from continuing financing activities
-145.01%-1.23B
125.51%2.68B
55.56%-972M
16.19%-2.7B
247.34%3.63B
202.87%2.73B
7.40%-10.52B
24.95%-2.19B
-66.74%-3.22B
26.03%-2.46B
Net issuance payments of debt
-55.25%2.5B
288.36%7.93B
-1,350.00%-232M
26.97%-1.95B
398.48%4.52B
40,021.43%5.59B
54.56%-4.21B
99.34%-16M
-88.68%-2.67B
42.31%-1.52B
Net common stock issuance
-50.00%-3.03B
42.51%-2.01B
100.07%1M
--3M
--2M
-0.90%-2.02B
---3.5B
---1.5B
--0
--0
Cash dividends paid
-7.83%-840M
-7.74%-3.13B
-8.34%-779M
-7.30%-779M
-7.43%-795M
-7.89%-779M
-10.74%-2.91B
-8.94%-719M
-10.17%-726M
-13.85%-740M
Proceeds from stock option exercised by employees
111.46%203M
-49.73%277M
-14.63%35M
-24.69%122M
-52.94%24M
-67.68%96M
0.36%551M
-62.39%41M
47.27%162M
-56.78%51M
Net other financing activities
60.49%-64M
14.92%-382M
-57.14%3M
-900.00%-96M
50.58%-127M
23.22%-162M
-3,353.85%-449M
-89.71%7M
-62.50%12M
-52.07%-257M
Cash from discontinued financing activities
Financing cash flow
-145.01%-1.23B
125.51%2.68B
55.56%-972M
16.19%-2.7B
247.34%3.63B
202.87%2.73B
7.40%-10.52B
24.95%-2.19B
-66.74%-3.22B
26.03%-2.46B
Net cash flow
Beginning cash position
-35.93%8.53B
4.84%13.31B
-23.85%13.38B
13.35%14.13B
28.80%14.96B
4.84%13.31B
14.92%12.69B
34.69%17.56B
21.05%12.46B
30.71%11.61B
Current changes in cash
-4.12%1.58B
-878.50%-4.78B
-13.90%-4.85B
-114.75%-752M
-197.18%-828M
252.78%1.65B
-62.74%614M
-1,120.06%-4.26B
85.86%5.1B
-39.70%852M
End cash Position
-32.42%10.11B
-35.93%8.53B
-35.93%8.53B
-23.85%13.38B
13.35%14.13B
28.80%14.96B
4.84%13.31B
4.84%13.31B
34.69%17.56B
21.05%12.46B
Free cash flow
-34.96%4.2B
-22.71%10.4B
-34.36%-3.55B
-74.59%2.17B
5.60%5.32B
156.93%6.45B
-14.58%13.45B
-177.46%-2.64B
73.89%8.54B
-6.08%5.04B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.08%4.9B-17.01%13.43B-35.04%-2.64B-70.23%2.72B8.54%5.91B108.76%7.44B-11.43%16.18B-148.74%-1.95B65.24%9.12B-6.91%5.44B
Net income from continuing operations -47.53%1.12B93.39%8.37B-12.22%2.05B166.64%2.27B-37.02%1.91B-9.04%2.14B-45.84%4.33B68.13%2.33B-314.18%-3.4B8.89%3.04B
Operating gains losses -----83.04%349M--0------------355.31%2.06B-367.42%-238M--2.52B----
Depreciation and amortization 13.69%1.14B3.36%4.37B8.72%1.13B7.33%1.13B2.03%1.1B-4.58%1B-5.84%4.22B-4.22%1.04B-7.41%1.05B-4.84%1.08B
Deferred tax -240.00%-217M66.68%-676M-271.74%-316M77.28%-447M4.23%-68M188.57%155M-404.73%-2.03B-24.28%184M-615.27%-1.97B65.20%-71M
Other non cash items ----25.30%416M----------------185.13%332M------------
Change In working capital -32.60%2.72B-99.78%15M-5.83%-6.04B-106.77%-732M87.22%2.75B1,547.76%4.04B76.77%6.82B-6,375.82%-5.71B398.98%10.81B-25.63%1.47B
-Change in receivables 500.53%3.01B-110.70%-6.26B-143.24%-2.34B-559.59%-3.12B92.64%-53M61.82%-751M-9.91%-2.97B-220.10%-962M160.54%678M-147.42%-720M
-Change in inventory 100.48%1.66B185.92%1.23B92.94%-72M44.00%-495M11.85%972M307.00%828M-295.24%-1.44B-181.77%-1.02B-110.48%-884M36.21%869M
-Change in payables and accrued expense -73.48%843M-23.61%4.01B-21.72%-3.13B-35.01%2.93B1,320.00%1.04B-6.61%3.18B75.13%5.25B-94.70%-2.57B79.20%4.51B-109.08%-85M
-Change in other current assets -125.98%-2.84B-3.87%-510M103.24%8M840.48%395M451.61%342M-260.63%-1.26B-1,536.67%-491M-525.86%-247M-67.94%42M-7.46%62M
-Change in other current liabilities -97.74%46M-76.17%1.54B44.16%-507M-106.88%-445M-66.10%456M558.56%2.04B126.30%6.46B-199.13%-908M509.80%6.47B114.17%1.35B
Cash from discontinued investing activities
Operating cash flow -34.08%4.9B-17.01%13.43B-35.04%-2.64B-70.23%2.72B8.54%5.91B108.76%7.44B-11.43%16.18B-148.74%-1.95B65.24%9.12B-6.91%5.44B
Investing cash flow
Cash flow from continuing investing activities 75.41%-2.09B-313.89%-20.89B-943.70%-1.24B4.22%-771M-386.48%-10.36B-327.20%-8.51B4.07%-5.05B91.74%-119M4.96%-805M-92.41%-2.13B
Net PPE purchase and sale 28.35%-705M-11.15%-3.03B-32.41%-911M6.03%-545M-44.85%-591M6.37%-984M-8.21%-2.73B-15.24%-688M4.61%-580M16.05%-408M
Net business purchase and sale 99.65%-25M-1,096.83%-16.61B-117.88%-120M-300.00%-18M-355.12%-9.38B-101,242.86%-7.09B-850.68%-1.39B6,200.00%671M133.33%9M-8,487.50%-2.06B
Net investment purchase and sale -198.07%-1.39B-29.20%-1.31B-108.85%-236M13.78%-219M-254.33%-392M48.34%-467M62.57%-1.02B86.85%-113M-8.09%-254M137.97%254M
Net other investing changes -9.68%28M-20.00%68M127.27%25M-45.00%11M-98.82%1M200.00%31M-30.33%85M-59.26%11M-13.04%20M--85M
Cash from discontinued investing activities
Investing cash flow 75.41%-2.09B-313.89%-20.89B-943.70%-1.24B4.22%-771M-386.48%-10.36B-327.20%-8.51B4.07%-5.05B91.74%-119M4.96%-805M-92.41%-2.13B
Financing cash flow
Cash flow from continuing financing activities -145.01%-1.23B125.51%2.68B55.56%-972M16.19%-2.7B247.34%3.63B202.87%2.73B7.40%-10.52B24.95%-2.19B-66.74%-3.22B26.03%-2.46B
Net issuance payments of debt -55.25%2.5B288.36%7.93B-1,350.00%-232M26.97%-1.95B398.48%4.52B40,021.43%5.59B54.56%-4.21B99.34%-16M-88.68%-2.67B42.31%-1.52B
Net common stock issuance -50.00%-3.03B42.51%-2.01B100.07%1M--3M--2M-0.90%-2.02B---3.5B---1.5B--0--0
Cash dividends paid -7.83%-840M-7.74%-3.13B-8.34%-779M-7.30%-779M-7.43%-795M-7.89%-779M-10.74%-2.91B-8.94%-719M-10.17%-726M-13.85%-740M
Proceeds from stock option exercised by employees 111.46%203M-49.73%277M-14.63%35M-24.69%122M-52.94%24M-67.68%96M0.36%551M-62.39%41M47.27%162M-56.78%51M
Net other financing activities 60.49%-64M14.92%-382M-57.14%3M-900.00%-96M50.58%-127M23.22%-162M-3,353.85%-449M-89.71%7M-62.50%12M-52.07%-257M
Cash from discontinued financing activities
Financing cash flow -145.01%-1.23B125.51%2.68B55.56%-972M16.19%-2.7B247.34%3.63B202.87%2.73B7.40%-10.52B24.95%-2.19B-66.74%-3.22B26.03%-2.46B
Net cash flow
Beginning cash position -35.93%8.53B4.84%13.31B-23.85%13.38B13.35%14.13B28.80%14.96B4.84%13.31B14.92%12.69B34.69%17.56B21.05%12.46B30.71%11.61B
Current changes in cash -4.12%1.58B-878.50%-4.78B-13.90%-4.85B-114.75%-752M-197.18%-828M252.78%1.65B-62.74%614M-1,120.06%-4.26B85.86%5.1B-39.70%852M
End cash Position -32.42%10.11B-35.93%8.53B-35.93%8.53B-23.85%13.38B13.35%14.13B28.80%14.96B4.84%13.31B4.84%13.31B34.69%17.56B21.05%12.46B
Free cash flow -34.96%4.2B-22.71%10.4B-34.36%-3.55B-74.59%2.17B5.60%5.32B156.93%6.45B-14.58%13.45B-177.46%-2.64B73.89%8.54B-6.08%5.04B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg